Item 9 Labs Corp.
INLB · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $2 | $6 | $2 | $0 |
| Other Curr. Assets | $0 | $1 | $0 | $3 |
| Total Curr. Assets | $4 | $11 | $3 | $3 |
| Property Plant & Equip (Net) | $22 | $12 | $9 | $8 |
| Goodwill | $58 | $58 | $1 | $1 |
| Intangibles | $12 | $19 | $8 | $2 |
| Long-Term Investments | $8 | $18 | $0 | $0 |
| Tax Assets | -$8 | -$18 | -$0 | $0 |
| Other NC Assets | $15 | $18 | $0 | $1 |
| Total NC Assets | $107 | $106 | $18 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $111 | $117 | $21 | $14 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $2 | $1 |
| Short-Term Debt | $20 | $6 | $6 | $5 |
| Tax Payable | $0 | $3 | $2 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $3 | $1 | $1 |
| Total Curr. Liab. | $41 | $15 | $10 | $7 |
| LT Debt | $8 | $15 | $2 | $0 |
| Deferred Rev, NC | $0 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $16 | $2 | $3 |
| Other Liabilities | $0 | $0 | $0 | -$3 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $49 | $31 | $13 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$65 | -$34 | -$23 | -$11 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $127 | $120 | $31 | $18 |
| Total Equity | $62 | $86 | $8 | $7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | $0 | $0 | -$0 |
| Total Liab. & Tot. Equity | $111 | $117 | $21 | $14 |
| Net Debt | $28 | $20 | $8 | $5 |